| Net loss | -30.07M |
| Depreciation and amortization | |
| (Gain) loss on disposals of fixed assets | |
| Loss on fair value of warrants | |
| (Gain) loss on change in fair value of contingent consideration | |
| Expenses related to share-based compensation | 1.95M |
| Expense related to stock options issued to non-employees | |
| Expenses paid by issuance of common stock | |
| Expenses paid by issuance of warrants | |
| Expenses paid by issuance of preferred stock | |
| Expenses related to stock warrants issued | |
| Accretion of discount on investments in securities | |
| Amortization of debt discount | |
| Forgiveness of employee receivable | |
| Impairment loss - write-off of goodwill | |
| Equity in loss of investee | |
| In-process research and development | |
| Write-off of license agreement | |
| Write-off of assets available-for-sale | |
| Cumulative effect of change in accounting principle | |
| (Increase) decrease in prepaid expenses and other assets | 38K |
| Increase (decrease) in accounts payable and accrued liabilities | -2.9M |
| Net cash used in operating activities | |
| Purchases of short-term investments | |
| Proceeds from sales and maturities of short-term investments | |
| Purchases of property and equipment | -8K |
| Proceeds from sale of property and equipment | |
| Purchase of certificate of deposit | |
| Maturity of certificate of deposit | |
| Payment on obligation under license agreement | |
| Cash acquired from acquisitions, net of cash paid | |
| Issuance of note receivable - related party | |
| Payments on note receivable | |
| Advance to investee | |
| Cash transferred in rescission of acquisition | |
| Cash received in rescission of acquisition | |
| Net cash provided by (used in) investing activities | |
| Proceeds from sale of preferred stock | |
| Proceeds of restricted cash for preferred stock dividends | |
| Proceeds from sale of common stock | 17.94M |
| Proceeds from exercise of stock options | |
| Proceeds from sale or exercise of warrants | |
| Payment to escrow for preferred stock dividends obligation | |
| Repurchase of warrants | |
| Payments for financing and offering costs | -1.03M |
| Payments on notes payable and long-term debt | |
| Proceeds from issuance of notes payable and detachable warrants | |
| Cash paid in lieu of fractional shares for reverse stock split | |
| Net cash provided by financing activities | |
| Effect of exchange rate changes on cash | |
| Net increase in cash and cash equivalents | -2.53M |
| Cash and cash equivalents at beginning of period | 23.05M |
| Cash and cash equivalents at end of period | 20.52M |